vs
Side-by-side financial comparison of J.Jill, Inc. (JILL) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
J.Jill, Inc. is the larger business by last-quarter revenue ($150.5M vs $83.1M, roughly 1.8× PROCEPT BioRobotics Corp). J.Jill, Inc. runs the higher net margin — 6.1% vs -38.1%, a 44.2% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -0.5%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 0.1%).
J.Jill is an American womenswear retailer founded in 1955 in Massachusetts. It has been a publicly traded company since 2017. J.Jill is headquartered in Quincy, Massachusetts.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
JILL vs PRCT — Head-to-Head
Income Statement — Q3 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $150.5M | $83.1M |
| Net Profit | $9.2M | $-31.6M |
| Gross Margin | 70.9% | 64.9% |
| Operating Margin | 9.9% | -4.1% |
| Net Margin | 6.1% | -38.1% |
| Revenue YoY | -0.5% | 20.2% |
| Net Profit YoY | -25.5% | -27.9% |
| EPS (diluted) | $0.60 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $150.5M | $76.4M | ||
| Q3 25 | $154.0M | $83.3M | ||
| Q2 25 | $153.6M | $79.2M | ||
| Q1 25 | $142.8M | $69.2M | ||
| Q4 24 | $151.3M | $68.2M | ||
| Q3 24 | $155.2M | $58.4M | ||
| Q2 24 | $161.5M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $9.2M | $-29.8M | ||
| Q3 25 | $10.5M | $-21.4M | ||
| Q2 25 | $11.7M | $-19.6M | ||
| Q1 25 | $2.2M | $-24.7M | ||
| Q4 24 | $12.3M | $-18.9M | ||
| Q3 24 | $8.2M | $-21.0M | ||
| Q2 24 | $16.7M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | 70.9% | 60.6% | ||
| Q3 25 | 68.4% | 64.8% | ||
| Q2 25 | 71.8% | 65.4% | ||
| Q1 25 | 66.3% | 63.9% | ||
| Q4 24 | 71.4% | 64.0% | ||
| Q3 24 | 70.5% | 63.2% | ||
| Q2 24 | 72.9% | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 9.9% | -40.6% | ||
| Q3 25 | 10.9% | -27.8% | ||
| Q2 25 | 12.4% | -28.0% | ||
| Q1 25 | 3.6% | -39.7% | ||
| Q4 24 | 12.7% | -28.9% | ||
| Q3 24 | 14.8% | -38.4% | ||
| Q2 24 | 17.6% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 6.1% | -39.1% | ||
| Q3 25 | 6.8% | -25.7% | ||
| Q2 25 | 7.6% | -24.7% | ||
| Q1 25 | 1.6% | -35.8% | ||
| Q4 24 | 8.2% | -27.6% | ||
| Q3 24 | 5.3% | -35.9% | ||
| Q2 24 | 10.3% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $0.60 | $-0.54 | ||
| Q3 25 | $0.69 | $-0.38 | ||
| Q2 25 | $0.76 | $-0.35 | ||
| Q1 25 | $0.11 | $-0.45 | ||
| Q4 24 | $0.80 | $-0.34 | ||
| Q3 24 | $0.54 | $-0.40 | ||
| Q2 24 | $1.16 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $58.0M | $245.6M |
| Total DebtLower is stronger | — | $51.7M |
| Stockholders' EquityBook value | $129.0M | $347.7M |
| Total Assets | $458.0M | $487.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $58.0M | $286.5M | ||
| Q3 25 | $45.5M | $294.3M | ||
| Q2 25 | $31.2M | $302.7M | ||
| Q1 25 | $35.4M | $316.2M | ||
| Q4 24 | $38.8M | $333.7M | ||
| Q3 24 | $28.5M | $196.8M | ||
| Q2 24 | $77.1M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $129.0M | $365.9M | ||
| Q3 25 | $121.5M | $380.3M | ||
| Q2 25 | $112.0M | $385.8M | ||
| Q1 25 | $105.8M | $389.2M | ||
| Q4 24 | $103.3M | $402.2M | ||
| Q3 24 | $90.4M | $241.2M | ||
| Q2 24 | $53.1M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $458.0M | $508.1M | ||
| Q3 25 | $436.5M | $511.5M | ||
| Q2 25 | $432.9M | $513.1M | ||
| Q1 25 | $417.7M | $519.4M | ||
| Q4 24 | $418.3M | $534.0M | ||
| Q3 24 | $390.8M | $374.1M | ||
| Q2 24 | $443.9M | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $19.1M | — |
| Free Cash FlowOCF − Capex | $16.0M | — |
| FCF MarginFCF / Revenue | 10.6% | — |
| Capex IntensityCapex / Revenue | 2.0% | — |
| Cash ConversionOCF / Net Profit | 2.07× | — |
| TTM Free Cash FlowTrailing 4 quarters | $37.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $19.1M | $-10.3M | ||
| Q3 25 | $19.4M | $-6.6M | ||
| Q2 25 | $5.3M | $-15.0M | ||
| Q1 25 | $8.1M | $-17.0M | ||
| Q4 24 | $19.1M | $-32.4M | ||
| Q3 24 | $16.4M | $-18.8M | ||
| Q2 24 | $21.5M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $16.0M | $-12.2M | ||
| Q3 25 | $17.1M | $-9.5M | ||
| Q2 25 | $3.1M | $-17.8M | ||
| Q1 25 | $1.4M | $-18.8M | ||
| Q4 24 | $14.6M | $-33.6M | ||
| Q3 24 | $15.0M | $-19.0M | ||
| Q2 24 | $19.8M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | 10.6% | -15.9% | ||
| Q3 25 | 11.1% | -11.4% | ||
| Q2 25 | 2.0% | -22.5% | ||
| Q1 25 | 1.0% | -27.2% | ||
| Q4 24 | 9.7% | -49.2% | ||
| Q3 24 | 9.6% | -32.6% | ||
| Q2 24 | 12.2% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 2.0% | 2.4% | ||
| Q3 25 | 1.5% | 3.4% | ||
| Q2 25 | 1.5% | 3.5% | ||
| Q1 25 | 4.7% | 2.7% | ||
| Q4 24 | 2.9% | 1.7% | ||
| Q3 24 | 0.9% | 0.4% | ||
| Q2 24 | 1.1% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 2.07× | — | ||
| Q3 25 | 1.84× | — | ||
| Q2 25 | 0.46× | — | ||
| Q1 25 | 3.60× | — | ||
| Q4 24 | 1.54× | — | ||
| Q3 24 | 2.00× | — | ||
| Q2 24 | 1.29× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
JILL
| Sales Channel Through Intermediary | $80.1M | 53% |
| Sales Channel Directly To Consumer | $70.5M | 47% |
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
